Mains publications

Main Publications o the lab

For the full list, see the home page of each team:

Pierre Desreumaux

Daniel Poulain Monique Capron Frédéric Gottrand Yazdan Yazandanpanah

2011 2010 2009

2011



H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy
Rahier JF, Papay P, Salleron J, Sebastian S, Marzo M, Peyrin-Biroulet L, Garcia-Sanchez V, Fries W, van Asseldonk DP, Farkas K, de Boer NK, Sipponen T, Ellul P, Louis E, Peake ST, Kopylov U, Maul J, Makhoul B, Fiorino G, Yazdanpanah Y, Chaparro M; for the European Crohn’s and Colitis Organisation (ECCO)
Gut 2011


Top

2010

Infliximab, azathioprine, or combination therapy for Crohn’s disease
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D’Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P; SONIC Study Group
N Engl J Med. 2010 ; 362(15):1383-95

Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells
Legrand F, Driss V, Delbeke M, Loiseau S, Hermann E, Dombrowicz D, Capron M
J Immunol. 2010; 185(12):7443-51

Breast-feeding modulates the influence of the peroxisome proliferator-activated receptor-gamma (PPARG2) Pro12Ala polymorphism on adiposity in adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) cross-sectional study
Verier C, Meirhaeghe A, Bokor S, Breidenassel C, Manios Y, Molnár D, Artero EG, Nova E, De Henauw S, Moreno LA, Amouyel P, Labayen I, Bevilacqua N, Turck D, Béghin L, Dallongeville J, Gottrand F; Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) Study Group
Diabetes Care 2010 ; 33(1):190-6

Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control
Dharancy S, Body-Malapel M, Louvet A, Berrebi D, Gantier E, Gosset P, Viala J, Hollebecque A, Moreno C, Philpott DJ, Girardin SE, Sansonetti PJ, Desreumaux P, Mathurin P, Dubuquoy L
Gastroenterology 2010 ; 138(4):1546-56

Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, Parmentier-Decrucq E, Dessein R, Merour E, Chavatte P, Grandjean T, Bressenot A, Desreumaux P, Colombel JF, Desvergne B, Stange EF, Wehkamp J, Chamaillard M
Proc Natl Acad Sci U S A. 2010 ; 107(19):8772-7


Top

2009

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group
Lancet 2009 ; 374(9701):1617-25

The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?
Rahier JF, Yazdanpanah Y, Colombel JF, Travis S
Gut 2009 ; 58(10):1313-5

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF
Gastroenterology 2009 ; 137(4):1250-60

TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins
Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, Kremer L, Adam E, Woerly G, Dombrowicz D, Capron M
Blood 2009 ; 113(14):3235-44

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D’Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lomax KG, Pollack PF
Gut 2009 ; 58(7):940-8


Top